Related Experiment Video
Updated: Feb 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study
Chadia Haddad1,2, Souheil Hallit1,3,4,5,2, Pascale Salameh3,6
1Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon.
Insights
Coronary heart disease (CHD) risk is significant in Lebanese schizophrenia patients. Metabolic syndrome and longer illness duration increase risk, while certain medications may lower it.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Coronary heart disease (CHD) is a major cause of early mortality in schizophrenia patients.
- CHD risk in the Lebanese schizophrenia population is currently unknown.
Purpose of the Study:
- To assess the 10-year hard CHD risk in Lebanese schizophrenia patients.
- To identify modifiable and non-modifiable factors influencing CHD risk in this population.
Main Methods:
- A cross-sectional study involving 329 schizophrenia patients aged 20-75 years.
- Ten-year hard CHD risk calculated using the Framingham risk score.
- Logistic regression analysis to determine factors associated with CHD risk.
Main Results:
- 60.8% of patients had low (<10%), 31.6% intermediate (10-20%), and 7.6% high (>20%) 10-year hard CHD risk.
- Higher risk observed with metabolic syndrome, longer schizophrenia duration, and co-existing medical illnesses.
- Certain medications (risperidone, anti-epileptics, benzodiazepines) were associated with lower CHD risk.
Conclusions:
- Coronary heart disease is prevalent among schizophrenia patients in Lebanon.
- Monitoring metabolic syndrome components is crucial for identifying high-risk individuals.
- Targeted interventions are needed to mitigate cardiovascular disease risk in this vulnerable group.
Background:
Coronary heart disease (CHD) is a leading cause of premature death in patients with schizophrenia. CHD risk in Lebanese patients with schizophrenia remains unknown.
Objectives:
To (i) evaluate CHD risk of patients with schizophrenia in Lebanon; and (ii) detect the modifiable and non-modifiable factors affecting this risk.
Methods:
Cross-sectional study of 329 patients with schizophrenia aged 20-75 years. Ten-year hard CHD risk was calculated using the Framingham risk score. A logistic regression was conducted taking the dichotomous hard CHD (<10% and ≥10%) as the dependent variable.
Results:
Ten-year hard CHD risk was low (<10%) in 60.8% of patients, intermediate (10-20%) in 31.6%, and high (>20%) in 7.6%. Multivariate analysis showed that the mean 10-year hard CHD risk was 8.76±6.92 (10.82±6.83 in men and 3.18±2.90 in women). Ten-year hard CHD risk was higher in patients with the metabolic syndrome (odds ratio [OR] 2.67, confidence interval [CI] 1.54-4.64), a longer duration of schizophrenia (OR 1.03, CI 1.01-1.05), a history of other medical illnesses (OR 2.02, CI 1.18-3.47), and in those participating in art therapy (OR 2.13, CI 1.25-3.64) or therapeutic education (OR 1.93, CI 0.93-4.01). Ten-year hard CHD risk was lower in patients receiving risperidone (OR 0.23, CI 0.08-0.68), any anti-epileptic (OR 0.41, CI 0.24-0.73), or any benzodiazepine (OR 0.33, CI 0.17-0.66) medication.
Conclusion:
CHD is prevalent in patients with schizophrenia in Lebanon. Physicians are recommended to monitor the components of the metabolic syndrome to identify patients with increased risk of cardiovascular diseases.
More Related Videos
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction

